Author:
Hirst David G.,Robson Tracy
Reference90 articles.
1. Adams, C., McCarthy, H.O., Coulter, J.A., Worthington, J., Murphy, C., Robson, T., and Hirst, D.G. (2008). Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells. J. Gene Med. (Dec 8) (Epub ahead of print).
2. Adams, D.J., Levesque, M.C., Weinberg, J.B., Smith, K.L., Flowers, J.L., Moore, J., Colvin, O.M., and Silber, R. (2001). Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes. Leukemia: Official J. Leukemia Soc. Am. Leukemia Res. Fund, U.K 15(12), 1852–1859.
3. Aranda, M. and Pearl, R.G. (2000). Inhaled nitric oxide and pulmonary vasoreactivity. J. Clin. Monot. Comp. 16(5–6), 393–401.
4. Azizzadeh, B., Yip, H.T., Blackwell, K.E., Horvath, S., Calcaterra, T.C., Buga, G.M., Ignarro, L.J., and Wang, M.B. (2001). Nitric oxide improves cisplatin cytotoxicity in head and neck squamous cell carcinoma. The Laryngoscope 111(11 Pt 1), 1896–1900.
5. Berge, D.L., Ridder, M.D., Verovski, V.N., Janssens, M.Y., Monsaert, C., and Storme, G.A. (2001). Chronic hypoxia modulates tumour cell radioresponse through cytokine-inducible nitric oxide synthase. Br. J. Cancer 84(8), 1122–1125.